# Symptom Management Implementation of Patient Reported Outcomes in Oncology

> **NCT03850912** · NA · COMPLETED · sponsor: **Dana-Farber Cancer Institute** · enrollment: 42808 (actual)

## Conditions studied

- Other Cancer
- Gastrointestinal Cancer
- Thoracic Cancer
- Gynecologic Cancer

## Interventions

- **OTHER:** Stakeholder Survey (Control Period)
- **OTHER:** Stakeholder Survey (Intervention Period)
- **OTHER:** Qualitative Interview
- **OTHER:** SASS Questionnaire
- **OTHER:** eSyM

## Key facts

- **NCT ID:** NCT03850912
- **Lead sponsor:** Dana-Farber Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-07-25
- **Primary completion:** 2023-03-31
- **Final completion:** 2025-06-09
- **Target enrollment:** 42808 (ACTUAL)
- **Last updated:** 2025-08-27

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03850912

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03850912, "Symptom Management Implementation of Patient Reported Outcomes in Oncology". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT03850912. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*